# Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.

> **NCT06489613** · — · NOT_YET_RECRUITING · sponsor: **Jian Li** · enrollment: 15600 (estimated)

## Conditions studied

- M Protein
- Monoclonal Gammopathy
- Monoclonal Gammopathy of Undetermined Significance

## Interventions

- **DIAGNOSTIC_TEST:** M protein detection by iMS-LC Assay

## Key facts

- **NCT ID:** NCT06489613
- **Lead sponsor:** Jian Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 15600 (ESTIMATED)
- **Last updated:** 2024-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06489613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06489613, "Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06489613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*